Locally based Prairie Plant Systems, a division of CanniMed, is funding Health Canada’s first approved medical marijuana clinical trial. The Saskatoon business will also provide all cannabis for the research.
The study will take place over the next 12 to 18 months, using five different strains of vaporized cannabis with varying amounts of the active ingredients delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
The research will take place at McGill University Health Centre in Montreal and Dalhousie University in Halifax, N.S.
– Read the entire article at Global News.